Total trials
384
Active
52
Phase 3
31
Total enrollment
14,719,514
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tranexamic Acid | — | — | — | — | — | 1 | |
| FoodRx | — | — | — | — | — | 1 | |
| Niacinamide | — | — | — | — | — | 1 |
Next readouts
- 2025-04-30
- 2025-07
- 2026-06-01
Top conditions
- Obesity26
- Depression22
- Diabetes Mellitus, Type 212
- Colorectal Cancer10
- Diabetes10
- Hypertension9
- Diabetes Mellitus8
- Cardiovascular Diseases8
Frequently asked questions about Kaiser Permanente
- How many clinical trials does Kaiser Permanente have on ClinicalTrials.gov?
- Kaiser Permanente is listed as the lead sponsor on 384 clinical trials in ClinicalTrials.gov, 52 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Kaiser Permanente's trials are in Phase 3?
- 31 of Kaiser Permanente's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Kaiser Permanente focus on?
- Kaiser Permanente's most-studied conditions on ClinicalTrials.gov are Obesity, Depression, Diabetes Mellitus, Type 2, Colorectal Cancer, Diabetes.
- When are Kaiser Permanente's next clinical trial readouts?
- Kaiser Permanente has 3 upcoming primary-completion readouts tracked here; the soonest is “NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial”, expected around 2025-04-30.